Matches in Wikidata for { <http://www.wikidata.org/entity/Q90420339> ?p ?o ?g. }
- Q90420339 description "articolo scientifico (pubblicato il 2019)" @default.
- Q90420339 description "artikull shkencor i botuar më 01 shkurt 2019" @default.
- Q90420339 description "artículu científicu espublizáu en febreru de 2019" @default.
- Q90420339 description "im Februar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90420339 description "scientific article published on 01 February 2019" @default.
- Q90420339 description "wetenschappelijk artikel" @default.
- Q90420339 description "наукова стаття, опублікована 1 лютого 2019" @default.
- Q90420339 name "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib" @default.
- Q90420339 name "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib" @default.
- Q90420339 name "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib" @default.
- Q90420339 type Item @default.
- Q90420339 label "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib" @default.
- Q90420339 label "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib" @default.
- Q90420339 label "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib" @default.
- Q90420339 prefLabel "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib" @default.
- Q90420339 prefLabel "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib" @default.
- Q90420339 prefLabel "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib" @default.
- Q90420339 P1433 Q90420339-FA936AFC-E27A-4971-AFC8-7EEB616AAED4 @default.
- Q90420339 P1476 Q90420339-BE63BEC6-2584-41C3-B04D-19257BC18A86 @default.
- Q90420339 P2093 Q90420339-0324D6AB-3A08-4DAD-8C03-B9BC5490EEBC @default.
- Q90420339 P2093 Q90420339-45297656-1496-4DEE-9A37-FAB365316A28 @default.
- Q90420339 P2093 Q90420339-48DBF0FD-A52B-4431-A88F-01F0BCCF8680 @default.
- Q90420339 P2093 Q90420339-82CADBB3-D402-444D-A4C8-FE2E70F8FC0E @default.
- Q90420339 P2093 Q90420339-98B73295-1090-4027-AA4D-6EFF4D12A7D7 @default.
- Q90420339 P2093 Q90420339-9916BE86-852B-49AD-B94B-C5E58D502E24 @default.
- Q90420339 P2093 Q90420339-BE2AAC20-1E09-4FC9-9CB9-E0F27482A170 @default.
- Q90420339 P2093 Q90420339-CD831469-7D74-441D-B57D-F731CD494006 @default.
- Q90420339 P2093 Q90420339-E67B1FAD-D849-4134-B058-77A00498E5AD @default.
- Q90420339 P275 Q90420339-8afa9349-7da5-4b7b-8076-8ab71b4f413d @default.
- Q90420339 P2860 Q90420339-1E8FF221-FCA5-4169-B577-D11B8749E729 @default.
- Q90420339 P2860 Q90420339-24685F70-24F8-4B7B-AB16-F0153B794E20 @default.
- Q90420339 P2860 Q90420339-3AEEB6B4-FE03-4C4A-B178-94743A754224 @default.
- Q90420339 P2860 Q90420339-40C7222A-C623-4E30-A437-86BC25EDA067 @default.
- Q90420339 P2860 Q90420339-46F67038-659C-4372-BC68-434B6D0379E4 @default.
- Q90420339 P2860 Q90420339-669F6101-6980-4592-849F-428D02EABE12 @default.
- Q90420339 P2860 Q90420339-6949FD41-E93C-40A2-AC6F-F9CE9C9336BC @default.
- Q90420339 P2860 Q90420339-69B92C77-5BE6-4E30-B17D-011E81DD9108 @default.
- Q90420339 P2860 Q90420339-6C789FF3-FF03-481B-88A1-AFA71569AFC8 @default.
- Q90420339 P2860 Q90420339-723CBDD8-5D24-47B0-AA92-7AD0744AF722 @default.
- Q90420339 P2860 Q90420339-74581AE7-0686-47FA-801E-59935582A05E @default.
- Q90420339 P2860 Q90420339-7E19C837-9360-4D5E-88C0-F95A65A88043 @default.
- Q90420339 P2860 Q90420339-8FA20678-398B-4F1D-BAE9-4999CFC6D432 @default.
- Q90420339 P2860 Q90420339-90C8B4DC-493A-4D0D-A885-3B706B8240B2 @default.
- Q90420339 P2860 Q90420339-98069897-73B9-4A50-8753-0ADB0BF59C72 @default.
- Q90420339 P2860 Q90420339-A099991D-C55B-4395-9684-9CD622BD060C @default.
- Q90420339 P2860 Q90420339-A14A10BE-DA12-486D-B1AB-005ABE0FD8ED @default.
- Q90420339 P2860 Q90420339-BF4E2872-7A3B-401E-BCF8-2DAF1934A5D5 @default.
- Q90420339 P2860 Q90420339-C34BE78B-46A8-4D18-9690-8960E48A8658 @default.
- Q90420339 P2860 Q90420339-CB4117EC-B3A5-498E-B713-AD7D0DBE4D92 @default.
- Q90420339 P2860 Q90420339-DF7FE9C0-D66A-4DB6-941E-B60EB746A5BC @default.
- Q90420339 P2860 Q90420339-FA9C2B30-D19B-4242-8B39-3BF5BE95AD71 @default.
- Q90420339 P304 Q90420339-D3D7BB3F-BE5C-4340-86B6-26C205ED06DE @default.
- Q90420339 P31 Q90420339-B4911CEB-D487-4067-A016-BF7F7706CA67 @default.
- Q90420339 P356 Q90420339-6DF70DAD-0199-43FA-A1E7-DA4646AA1ECF @default.
- Q90420339 P433 Q90420339-29679AFF-1C9E-49F1-99B8-D29408643522 @default.
- Q90420339 P478 Q90420339-2113BBE7-0B57-46CC-906F-AD3DDEF10741 @default.
- Q90420339 P577 Q90420339-CD52AEF4-D1AD-412D-9B83-3DC2ABE9026A @default.
- Q90420339 P6216 Q90420339-8e3077df-5e6f-4a9e-b8bb-9ad453497f1d @default.
- Q90420339 P698 Q90420339-ED58C50C-E992-4BB4-93E6-FBE67CF7594B @default.
- Q90420339 P932 Q90420339-B25924F7-58B7-44CE-9D35-EF878460FCF6 @default.
- Q90420339 P356 S11523-018-0612-Z @default.
- Q90420339 P698 30539501 @default.
- Q90420339 P1433 Q25378200 @default.
- Q90420339 P1476 "Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib" @default.
- Q90420339 P2093 "Agnieszka Cseh" @default.
- Q90420339 P2093 "Anna Buder" @default.
- Q90420339 P2093 "Helmut Prosch" @default.
- Q90420339 P2093 "Martin Filipits" @default.
- Q90420339 P2093 "Maximilian J Hochmair" @default.
- Q90420339 P2093 "Otto C Burghuber" @default.
- Q90420339 P2093 "Richard Fritz" @default.
- Q90420339 P2093 "Sophia Schwab" @default.
- Q90420339 P2093 "Wolfgang Hilbe" @default.
- Q90420339 P275 Q34179348 @default.
- Q90420339 P2860 Q27851633 @default.
- Q90420339 P2860 Q27852116 @default.
- Q90420339 P2860 Q34535332 @default.
- Q90420339 P2860 Q36286092 @default.
- Q90420339 P2860 Q37022191 @default.
- Q90420339 P2860 Q37629050 @default.
- Q90420339 P2860 Q38807486 @default.
- Q90420339 P2860 Q38809376 @default.
- Q90420339 P2860 Q40364937 @default.
- Q90420339 P2860 Q41646881 @default.
- Q90420339 P2860 Q42017572 @default.
- Q90420339 P2860 Q42283950 @default.
- Q90420339 P2860 Q43515871 @default.
- Q90420339 P2860 Q47257690 @default.
- Q90420339 P2860 Q47450132 @default.
- Q90420339 P2860 Q47730834 @default.
- Q90420339 P2860 Q48020812 @default.
- Q90420339 P2860 Q49300205 @default.
- Q90420339 P2860 Q52673818 @default.
- Q90420339 P2860 Q58587623 @default.
- Q90420339 P2860 Q59587212 @default.
- Q90420339 P2860 Q91517934 @default.
- Q90420339 P304 "75-83" @default.
- Q90420339 P31 Q13442814 @default.
- Q90420339 P356 "10.1007/S11523-018-0612-Z" @default.
- Q90420339 P433 "1" @default.